George Mason University

BioNTech Gets €375m From Germany To Fund Vaccine BioNTech SE has received €375m ($444m) from the German government to cover costs of the Phase II/III development program for its COVID-19 vaccine in

The fight against infectious disease presents a revealing truth to medical practice: as hard as it is to understand the intricate variations in the life cycle of a single pathogen, it is harder still

In Vitro Diagnostics ImmunoCellular Therapeutics Ltd. George Mason University ImmunoCellular, George Mason Univ. develop blood test June — ImmunoCellular Therapeutics (immune-based cancer treatments

by Beth Detuzzi Mergers & Acquisitions Amic AB & Ortho-Clinical Diagnostics Inc. (a division of Johnson & Johnson) Johnson & Johnson has acquired Amic , a private company developing point-of-care